Quick Answer
Cannabis Bioscience International Holdings, Inc. reported Net Income Loss of -$548.8 thousand for the year ending 2025.
- Cannabis Bioscience International Holdings, Inc. showed an increase of +15.7% in Net Income Loss from 2024 to 2025.
- This data is from Cannabis Bioscience International Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on September 22, 2025.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2010: $4.88 million | Q1 2011: -$1.67 million | Q4 2011: $1.81 million | Q1 2012: -$1.24 million | Q3 2022: -$212.0 thousand | Q4 2022: -$219.9 thousand | Q1 2023: -$324.7 thousand | Q3 2023: -$181.8 thousand | Q4 2023: -$124.4 thousand | Q1 2024: -$209.2 thousand | Q3 2024: -$76.3 thousand | Q4 2024: -$79.5 thousand | Q3 2025: -$82.6 thousand | Q4 2025: -$117.0 thousand.
- Over the full 3 years of available data (2023 to 2025), Cannabis Bioscience International Holdings, Inc.'s Net Income Loss has grown by 46.8%.
- Historical annual values: Fiscal year 2025: -$548.8 thousand | Fiscal year 2024: -$651.3 thousand | Fiscal year 2023: -$1.03 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: